| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ... The lancet oncology 18 (12), 1688-1700, 2017 | 641 | 2017 |
| Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma B Sarcevic, GC Spagnoli, L Terracciano, E Schultz-Thater, M Heberer, ... Oncology 64 (4), 443-449, 2003 | 65 | 2003 |
| Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer B Matkovic, A Juretic, V Separovic, I Novosel, R Separovic, M Gamulin, ... Tumori Journal 94 (6), 838-844, 2008 | 54 | 2008 |
| Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study B Matković, A Juretić, GC Spagnoli, V Šeparović, M Gamulin, R Šeparović, ... Croatian medical journal 52 (2), 171-177, 2011 | 34 | 2011 |
| Characteristics and prognosis of triple-negative breast cancer patients: a Croatian single institution retrospective cohort study A Tečić Vuger, R Šeparović, L Vazdar, M Pavlović, P Lepetić, S Šitić, ... Acta clinica Croatica 59 (1.), 97-107, 2020 | 24 | 2020 |
| PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial SKL Chia, M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ... Breast cancer research 21, 1-9, 2019 | 22 | 2019 |
| Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika oboljelih od raka debelog crijeva E Vrdoljak, S Pleština, T Omrčen, A Juretić, IB Lovasić, Ž Krznarić, J Flam, ... Liječnički vjesnik 140 (9-10), 241-247, 2018 | 17 | 2018 |
| Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial FA Holmes, B Moy, S Delaloge, SKL Chia, B Ejlertsen, J Mansi, H Iwata, ... European Journal of Cancer 184, 48-59, 2023 | 14 | 2023 |
| Kliničke upute hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ... Liječnički vjesnik 137 (5-6), 0-0, 2015 | 13 | 2015 |
| Trastuzumab plus capecitabine with or without pertuzumab in patients with HER2-positive MBC whose disease has progressed during or following trastuzumab-based therapy for first … M Munoz-Mateu, A Urruticoechea, R Separovic, J Erfán, TD Bachelot, ... Journal of Clinical Oncology 29 (15_suppl), TPS118-TPS118, 2011 | 13 | 2011 |
| Unusual features of metastatic atypical carcinoid of the larynx A Alujević, G Jurić, R Šeparović, B Krušlin European archives of oto-rhino-laryngology 255, 318-321, 1998 | 13 | 1998 |
| Isolated splenic metastasis from colorectal carcinoma in a high risk patient: a case report M Pavlović, R Šeparović, M Vukelić-Marković, L Patrlj, M Kolovrat, ... Collegium antropologicum 35 (4), 1307-1310, 2011 | 11 | 2011 |
| Kliničke upute za dijagnozu, liječenje i praćenje bolesnika oboljelih od kolorektalnog raka E Vrdoljak, S Pleština, R Dobrila Dintinjana, I Tomaš, H Šobat, ... Liječnički vjesnik 133 (11-12), 0-0, 2011 | 11 | 2011 |
| ASSOCIATION OF BREAST CANCER SYMPTOMS WITH PATIENTS’QUALITY OF LIFE AND DEPRESSION; A CROATIAN CROSS-SECTIONAL STUDY R Šeparović, T Silovski, A Tecić Vuger, Ž Bajić, H Silovski, A Jurić Psychiatria Danubina 31 (suppl. 1), 92-98, 2019 | 10 | 2019 |
| SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA–KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak … N Dedić Plavetić, T Silovski, A Tečić Vuger, M Pavlović, L Vazdar, ... Liječnički vjesnik 140 (3-4), 0-0, 2018 | 9 | 2018 |
| Clinical guidelines for diagnosis, treatment and monitoring of patients with invasive breast cancer–Croatian Oncology Society R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ... Liječnički vjesnik 137 (5-6), 0-0, 2015 | 9 | 2015 |
| Parachordoma: a case report R Šeparović, I Glumbić, B Pigac, V Šeparović, B Krušlin Tumori Journal 87 (3), 207-210, 2001 | 9 | 2001 |
| Rapid hair depigmentation in patient treated with pazopanib R Šeparović, M Pavlović, T Silovski, AT Vuger Case Reports 2018, bcr-2018-224209, 2018 | 8 | 2018 |
| Smjernice za provođenje dijagnostičkih pretraga prije početka liječenja onkološkog bolesnika–kliničke preporuke hrvatskog društva za internističku onkologiju hlz-a i. dio … R Šeparović, L Vazdar, A Tečić Vuger, M Pavlović, M Gnjidić, J Prejac, ... Liječnički vjesnik 140 (3-4), 0-0, 2018 | 8 | 2018 |
| Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer L Vazdar, ID Gabrić, I Kruljac, H Pintarić, R Šeparović, LS Kirigin Biloš, ... Scientific reports 11 (1), 14395, 2021 | 7 | 2021 |
